CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)

被引：36
|
作者：
Najjar, Sonia M. [1 ,2 ]
Russo, Lucia [1 ,2 ]
机构：
[1] Univ Toledo, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA
[2] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Toledo, OH 43614 USA
来源：
SEMINARS IN IMMUNOPATHOLOGY | 2014年 / 36卷 / 01期
关键词：
CEACAM1; Insulin resistance; Adipokines; Metabolic syndrome; NASH; FATTY-LIVER-DISEASE; TUMOR-NECROSIS-FACTOR; CELL-ADHESION MOLECULE-1; KILLER T-CELLS; INDUCED OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM STRESS; COLONY-STIMULATING FACTOR; INDUCED HEPATIC STEATOSIS; RECEPTOR TYROSINE KINASE; KAPPA-B ACTIVATION;
D O I：
10.1007/s00281-013-0407-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Mounting epidemiological evidence points to an association between metabolic syndrome and non-alcoholic steatohepatitis (NASH), an increasingly recognized new epidemic. NASH pathologies include hepatocellular ballooning, lobular inflammation, hepatocellular injury, apoptosis, and hepatic fibrosis. We will review the relationship between insulin resistance and inflammation in visceral obesity and NASH in an attempt to shed more light on the pathogenesis of these major metabolic diseases. Moreover, we will identify loss of the carcinoembryonic antigen-related cell adhesion molecule 1 as a unifying mechanism linking the immunological and metabolic abnormalities in NASH.
引用
收藏
页码：55 / 71
页数：17
相关论文
共 50 条
  • [1] CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
    Sonia M. Najjar
    Lucia Russo
    Seminars in Immunopathology, 2014, 36 : 55 - 71
  • [2] Loss of Ceacam1 Leads to the Development of Non-Alcoholic Steatohepatitis.
    Ghosh, S.
    Patel, P. R.
    Kaw, M.
    Fernstrom, M. A.
    Bourey, R. E.
    Erickson, S. K.
    McInerney, M. F.
    Najjar, S. M.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [3] Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
    Heinrich, Garrett
    Ghadieh, Hilda E.
    Ghanem, Simona S.
    Muturi, Harrison T.
    Rezaei, Khadijeh
    Al-Share, Qusai Y.
    Bowman, Thomas A.
    Zhang, Deqiang
    Garofalo, Robert S.
    Yin, Lei
    Najjar, Sonia M.
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [4] Insulin resistance is an independent defect in non-alcoholic steatohepatitis (NASH).
    Vanni, E
    Bugianesi, E
    Gastaldelli, A
    Gambino, R
    Cassader, M
    Ponti, V
    Ferranninni, E
    Pagano, G
    Rizzetto, M
    HEPATOLOGY, 2001, 34 (04) : 361A - 361A
  • [5] Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH)
    Agarwal, N
    Sharma, BC
    HEPATOLOGY RESEARCH, 2005, 33 (02) : 92 - 96
  • [6] Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
    Luyckx, FH
    Lefebvre, PJ
    Scheen, AJ
    DIABETES & METABOLISM, 2000, 26 (02) : 98 - 106
  • [7] Insulin resistance in non-alcoholic steatohepatitis
    Cömert, B
    Mas, MR
    Erdem, H
    Dinc, A
    Saglamkaya, U
    Cigerim, M
    Kuzhan, O
    Unal, T
    Kocabalkan, F
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (04) : 353 - 358
  • [8] Non-alcoholic steatohepatitis (NASH)
    Michael F. Sorrell
    Sandeep Mukherjee
    Current Treatment Options in Gastroenterology, 1999, 2 (6) : 447 - 450
  • [9] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [10] CONTRIBUTION OF HEPATOCYTE-SPECIFIC PPAR GAMMA TO THE DEVELOPMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH), INSULIN RESISTANCE AND OBESITY
    Lee, Samuel
    Muratalla, Jose
    Diaz-Ruiz, Alberto
    Cordoba-Chacon, Jose
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1076 - 1076
12345